PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.86%
Revenue growth 1.25-1.5x INTC's 4.61%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
7.84%
Gross profit growth above 1.5x INTC's 3.50%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
55.61%
EBIT growth above 1.5x INTC's 0.58%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
50.63%
Operating income growth above 1.5x INTC's 0.58%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
68.30%
Net income growth above 1.5x INTC's 3.25%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
65.22%
EPS growth above 1.5x INTC's 1.82%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
72.73%
Diluted EPS growth above 1.5x INTC's 1.89%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.26%
Share reduction while INTC is at 0.46%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.94%
Reduced diluted shares while INTC is at 0.13%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.26%
Dividend growth at 75-90% of INTC's 0.30%. Bill Ackman would press for a stronger return if the balance sheet allows.
50.33%
OCF growth at 75-90% of INTC's 59.45%. Bill Ackman would demand better working capital management or cost discipline.
52.89%
FCF growth under 50% of INTC's 103950.00%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
157.09%
10Y revenue/share CAGR at 75-90% of INTC's 184.07%. Bill Ackman would press for new markets or product lines to narrow the gap.
22.78%
5Y revenue/share CAGR under 50% of INTC's 79.92%. Michael Burry would suspect a significant competitive gap or product weakness.
50.86%
3Y revenue/share CAGR at 50-75% of INTC's 87.46%. Martin Whitman would question if the firm lags behind competitor innovations.
190.70%
10Y OCF/share CAGR at 50-75% of INTC's 273.05%. Martin Whitman might fear a structural deficiency in operational efficiency.
-5.25%
Negative 5Y OCF/share CAGR while INTC is at 126.80%. Joel Greenblatt would question the firm’s operational model or cost structure.
34.69%
3Y OCF/share CAGR at 50-75% of INTC's 56.02%. Martin Whitman would suspect weaker recent execution or product competitiveness.
682.46%
Similar net income/share CAGR to INTC's 742.74%. Walter Schloss would see parallel tailwinds or expansions for both firms.
-7.84%
Negative 5Y net income/share CAGR while INTC is 155.87%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
90.65%
Below 50% of INTC's 891.35%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
63.47%
10Y equity/share CAGR at 75-90% of INTC's 82.28%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
22.37%
5Y equity/share CAGR at 50-75% of INTC's 42.13%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
34.60%
3Y equity/share CAGR at 75-90% of INTC's 39.18%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
643.71%
10Y dividend/share CAGR at 50-75% of INTC's 948.76%. Martin Whitman suspects the firm lags in returning cash to shareholders over the decade.
113.74%
5Y dividend/share CAGR 1.25-1.5x INTC's 87.52%. Bruce Berkowitz verifies that high dividend hikes remain sustainable, not a sign of over-distribution.
55.92%
3Y dividend/share CAGR 1.25-1.5x INTC's 50.20%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
10.22%
Our AR growth while INTC is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
1.73%
Inventory shrinking or stable vs. INTC's 9.24%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-2.44%
Negative asset growth while INTC invests at 0.74%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.05%
Under 50% of INTC's 3.84%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-11.01%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-5.70%
Our R&D shrinks while INTC invests at 4.66%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.30%
We cut SG&A while INTC invests at 8.01%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.